nodes	percent_of_prediction	percent_of_DWPC	metapath
Fentanyl—OPRK1—Progesterone—uterine cancer	0.224	0.323	CbGbCtD
Fentanyl—CYP3A7—Progesterone—uterine cancer	0.0891	0.128	CbGbCtD
Fentanyl—CYP3A7-CYP3A51P—Progesterone—uterine cancer	0.0891	0.128	CbGbCtD
Fentanyl—CYP3A5—Progesterone—uterine cancer	0.0668	0.0962	CbGbCtD
Fentanyl—ABCB1—Progesterone—uterine cancer	0.0435	0.0626	CbGbCtD
Fentanyl—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0393	0.0566	CbGbCtD
Fentanyl—ABCB1—Dactinomycin—uterine cancer	0.0345	0.0496	CbGbCtD
Fentanyl—CYP3A5—Etoposide—uterine cancer	0.0299	0.043	CbGbCtD
Fentanyl—CYP3A4—Progesterone—uterine cancer	0.0261	0.0375	CbGbCtD
Fentanyl—ABCB1—Etoposide—uterine cancer	0.0195	0.028	CbGbCtD
Fentanyl—ABCB1—Doxorubicin—uterine cancer	0.0133	0.0191	CbGbCtD
Fentanyl—CYP3A4—Etoposide—uterine cancer	0.0117	0.0168	CbGbCtD
Fentanyl—CYP3A4—Doxorubicin—uterine cancer	0.00796	0.0114	CbGbCtD
Fentanyl—Benazepril—MTHFR—uterine cancer	0.000437	0.763	CrCbGaD
Fentanyl—Methadone—CYP19A1—uterine cancer	0.000136	0.237	CrCbGaD
Fentanyl—Pollakiuria—Epirubicin—uterine cancer	0.00011	0.000362	CcSEcCtD
Fentanyl—Paraesthesia—Etoposide—uterine cancer	0.000109	0.000356	CcSEcCtD
Fentanyl—Weight increased—Epirubicin—uterine cancer	0.000108	0.000356	CcSEcCtD
Fentanyl—Weight decreased—Epirubicin—uterine cancer	0.000108	0.000354	CcSEcCtD
Fentanyl—Dyspnoea—Etoposide—uterine cancer	0.000108	0.000354	CcSEcCtD
Fentanyl—Hyperglycaemia—Epirubicin—uterine cancer	0.000107	0.000353	CcSEcCtD
Fentanyl—Somnolence—Etoposide—uterine cancer	0.000107	0.000353	CcSEcCtD
Fentanyl—Angina pectoris—Doxorubicin—uterine cancer	0.000107	0.000353	CcSEcCtD
Fentanyl—Pneumonia—Epirubicin—uterine cancer	0.000107	0.000351	CcSEcCtD
Fentanyl—Drowsiness—Epirubicin—uterine cancer	0.000106	0.000349	CcSEcCtD
Fentanyl—Infestation—Epirubicin—uterine cancer	0.000106	0.000349	CcSEcCtD
Fentanyl—Infestation NOS—Epirubicin—uterine cancer	0.000106	0.000349	CcSEcCtD
Fentanyl—Vomiting—Dactinomycin—uterine cancer	0.000106	0.000349	CcSEcCtD
Fentanyl—Bronchitis—Doxorubicin—uterine cancer	0.000106	0.000348	CcSEcCtD
Fentanyl—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000105	0.000346	CcSEcCtD
Fentanyl—Rash—Dactinomycin—uterine cancer	0.000105	0.000346	CcSEcCtD
Fentanyl—Decreased appetite—Etoposide—uterine cancer	0.000105	0.000345	CcSEcCtD
Fentanyl—Pancytopenia—Doxorubicin—uterine cancer	0.000105	0.000344	CcSEcCtD
Fentanyl—Renal failure—Epirubicin—uterine cancer	0.000104	0.000343	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Etoposide—uterine cancer	0.000104	0.000343	CcSEcCtD
Fentanyl—Fatigue—Etoposide—uterine cancer	0.000104	0.000342	CcSEcCtD
Fentanyl—Neuropathy peripheral—Epirubicin—uterine cancer	0.000104	0.000342	CcSEcCtD
Fentanyl—Stomatitis—Epirubicin—uterine cancer	0.000104	0.00034	CcSEcCtD
Fentanyl—Jaundice—Epirubicin—uterine cancer	0.000104	0.00034	CcSEcCtD
Fentanyl—Pain—Etoposide—uterine cancer	0.000103	0.000339	CcSEcCtD
Fentanyl—Constipation—Etoposide—uterine cancer	0.000103	0.000339	CcSEcCtD
Fentanyl—Conjunctivitis—Epirubicin—uterine cancer	0.000103	0.000339	CcSEcCtD
Fentanyl—Urinary tract infection—Epirubicin—uterine cancer	0.000103	0.000339	CcSEcCtD
Fentanyl—Dysuria—Doxorubicin—uterine cancer	0.000103	0.000339	CcSEcCtD
Fentanyl—Neutropenia—Doxorubicin—uterine cancer	0.000103	0.000339	CcSEcCtD
Fentanyl—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000102	0.000337	CcSEcCtD
Fentanyl—Sweating—Epirubicin—uterine cancer	0.000102	0.000335	CcSEcCtD
Fentanyl—Pollakiuria—Doxorubicin—uterine cancer	0.000102	0.000335	CcSEcCtD
Fentanyl—Haematuria—Epirubicin—uterine cancer	0.000101	0.000333	CcSEcCtD
Fentanyl—Hepatobiliary disease—Epirubicin—uterine cancer	0.0001	0.00033	CcSEcCtD
Fentanyl—Weight increased—Doxorubicin—uterine cancer	0.0001	0.00033	CcSEcCtD
Fentanyl—Epistaxis—Epirubicin—uterine cancer	0.0001	0.000329	CcSEcCtD
Fentanyl—Weight decreased—Doxorubicin—uterine cancer	9.97e-05	0.000328	CcSEcCtD
Fentanyl—Sinusitis—Epirubicin—uterine cancer	9.96e-05	0.000327	CcSEcCtD
Fentanyl—Feeling abnormal—Etoposide—uterine cancer	9.96e-05	0.000327	CcSEcCtD
Fentanyl—Hyperglycaemia—Doxorubicin—uterine cancer	9.94e-05	0.000327	CcSEcCtD
Fentanyl—Nausea—Dactinomycin—uterine cancer	9.92e-05	0.000326	CcSEcCtD
Fentanyl—Pneumonia—Doxorubicin—uterine cancer	9.88e-05	0.000325	CcSEcCtD
Fentanyl—Gastrointestinal pain—Etoposide—uterine cancer	9.88e-05	0.000325	CcSEcCtD
Fentanyl—Infestation—Doxorubicin—uterine cancer	9.83e-05	0.000323	CcSEcCtD
Fentanyl—Infestation NOS—Doxorubicin—uterine cancer	9.83e-05	0.000323	CcSEcCtD
Fentanyl—Drowsiness—Doxorubicin—uterine cancer	9.83e-05	0.000323	CcSEcCtD
Fentanyl—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	9.74e-05	0.00032	CcSEcCtD
Fentanyl—Bradycardia—Epirubicin—uterine cancer	9.71e-05	0.000319	CcSEcCtD
Fentanyl—Renal failure—Doxorubicin—uterine cancer	9.66e-05	0.000317	CcSEcCtD
Fentanyl—Neuropathy peripheral—Doxorubicin—uterine cancer	9.63e-05	0.000316	CcSEcCtD
Fentanyl—Urticaria—Etoposide—uterine cancer	9.6e-05	0.000315	CcSEcCtD
Fentanyl—Haemoglobin—Epirubicin—uterine cancer	9.58e-05	0.000315	CcSEcCtD
Fentanyl—Stomatitis—Doxorubicin—uterine cancer	9.58e-05	0.000315	CcSEcCtD
Fentanyl—Jaundice—Doxorubicin—uterine cancer	9.58e-05	0.000315	CcSEcCtD
Fentanyl—Rhinitis—Epirubicin—uterine cancer	9.56e-05	0.000314	CcSEcCtD
Fentanyl—Abdominal pain—Etoposide—uterine cancer	9.55e-05	0.000314	CcSEcCtD
Fentanyl—Body temperature increased—Etoposide—uterine cancer	9.55e-05	0.000314	CcSEcCtD
Fentanyl—Urinary tract infection—Doxorubicin—uterine cancer	9.55e-05	0.000314	CcSEcCtD
Fentanyl—Conjunctivitis—Doxorubicin—uterine cancer	9.55e-05	0.000314	CcSEcCtD
Fentanyl—Haemorrhage—Epirubicin—uterine cancer	9.53e-05	0.000313	CcSEcCtD
Fentanyl—Hypoaesthesia—Epirubicin—uterine cancer	9.49e-05	0.000312	CcSEcCtD
Fentanyl—Pharyngitis—Epirubicin—uterine cancer	9.46e-05	0.000311	CcSEcCtD
Fentanyl—Sweating—Doxorubicin—uterine cancer	9.42e-05	0.00031	CcSEcCtD
Fentanyl—Urinary tract disorder—Epirubicin—uterine cancer	9.42e-05	0.000309	CcSEcCtD
Fentanyl—Oedema peripheral—Epirubicin—uterine cancer	9.39e-05	0.000309	CcSEcCtD
Fentanyl—Haematuria—Doxorubicin—uterine cancer	9.37e-05	0.000308	CcSEcCtD
Fentanyl—Connective tissue disorder—Epirubicin—uterine cancer	9.37e-05	0.000308	CcSEcCtD
Fentanyl—Urethral disorder—Epirubicin—uterine cancer	9.35e-05	0.000307	CcSEcCtD
Fentanyl—Hepatobiliary disease—Doxorubicin—uterine cancer	9.29e-05	0.000305	CcSEcCtD
Fentanyl—Epistaxis—Doxorubicin—uterine cancer	9.27e-05	0.000305	CcSEcCtD
Fentanyl—Sinusitis—Doxorubicin—uterine cancer	9.22e-05	0.000303	CcSEcCtD
Fentanyl—Visual impairment—Epirubicin—uterine cancer	9.19e-05	0.000302	CcSEcCtD
Fentanyl—Erythema multiforme—Epirubicin—uterine cancer	9.01e-05	0.000296	CcSEcCtD
Fentanyl—Bradycardia—Doxorubicin—uterine cancer	8.98e-05	0.000295	CcSEcCtD
Fentanyl—Eye disorder—Epirubicin—uterine cancer	8.91e-05	0.000293	CcSEcCtD
Fentanyl—Hypersensitivity—Etoposide—uterine cancer	8.9e-05	0.000292	CcSEcCtD
Fentanyl—Tinnitus—Epirubicin—uterine cancer	8.89e-05	0.000292	CcSEcCtD
Fentanyl—Haemoglobin—Doxorubicin—uterine cancer	8.87e-05	0.000291	CcSEcCtD
Fentanyl—Flushing—Epirubicin—uterine cancer	8.85e-05	0.000291	CcSEcCtD
Fentanyl—Cardiac disorder—Epirubicin—uterine cancer	8.85e-05	0.000291	CcSEcCtD
Fentanyl—Rhinitis—Doxorubicin—uterine cancer	8.84e-05	0.000291	CcSEcCtD
Fentanyl—Haemorrhage—Doxorubicin—uterine cancer	8.82e-05	0.00029	CcSEcCtD
Fentanyl—Hypoaesthesia—Doxorubicin—uterine cancer	8.78e-05	0.000288	CcSEcCtD
Fentanyl—Pharyngitis—Doxorubicin—uterine cancer	8.76e-05	0.000288	CcSEcCtD
Fentanyl—Urinary tract disorder—Doxorubicin—uterine cancer	8.71e-05	0.000286	CcSEcCtD
Fentanyl—Oedema peripheral—Doxorubicin—uterine cancer	8.69e-05	0.000286	CcSEcCtD
Fentanyl—Asthenia—Etoposide—uterine cancer	8.67e-05	0.000285	CcSEcCtD
Fentanyl—Connective tissue disorder—Doxorubicin—uterine cancer	8.67e-05	0.000285	CcSEcCtD
Fentanyl—Angiopathy—Epirubicin—uterine cancer	8.65e-05	0.000284	CcSEcCtD
Fentanyl—Urethral disorder—Doxorubicin—uterine cancer	8.65e-05	0.000284	CcSEcCtD
Fentanyl—Immune system disorder—Epirubicin—uterine cancer	8.61e-05	0.000283	CcSEcCtD
Fentanyl—Mediastinal disorder—Epirubicin—uterine cancer	8.59e-05	0.000282	CcSEcCtD
Fentanyl—Chills—Epirubicin—uterine cancer	8.55e-05	0.000281	CcSEcCtD
Fentanyl—Pruritus—Etoposide—uterine cancer	8.55e-05	0.000281	CcSEcCtD
Fentanyl—Arrhythmia—Epirubicin—uterine cancer	8.52e-05	0.00028	CcSEcCtD
Fentanyl—Visual impairment—Doxorubicin—uterine cancer	8.5e-05	0.000279	CcSEcCtD
Fentanyl—Alopecia—Epirubicin—uterine cancer	8.43e-05	0.000277	CcSEcCtD
Fentanyl—Mental disorder—Epirubicin—uterine cancer	8.35e-05	0.000274	CcSEcCtD
Fentanyl—Erythema multiforme—Doxorubicin—uterine cancer	8.34e-05	0.000274	CcSEcCtD
Fentanyl—Malnutrition—Epirubicin—uterine cancer	8.3e-05	0.000273	CcSEcCtD
Fentanyl—Erythema—Epirubicin—uterine cancer	8.3e-05	0.000273	CcSEcCtD
Fentanyl—Diarrhoea—Etoposide—uterine cancer	8.27e-05	0.000272	CcSEcCtD
Fentanyl—Eye disorder—Doxorubicin—uterine cancer	8.24e-05	0.000271	CcSEcCtD
Fentanyl—Tinnitus—Doxorubicin—uterine cancer	8.23e-05	0.00027	CcSEcCtD
Fentanyl—Cardiac disorder—Doxorubicin—uterine cancer	8.19e-05	0.000269	CcSEcCtD
Fentanyl—Flushing—Doxorubicin—uterine cancer	8.19e-05	0.000269	CcSEcCtD
Fentanyl—Flatulence—Epirubicin—uterine cancer	8.18e-05	0.000269	CcSEcCtD
Fentanyl—Tension—Epirubicin—uterine cancer	8.14e-05	0.000268	CcSEcCtD
Fentanyl—Dysgeusia—Epirubicin—uterine cancer	8.13e-05	0.000267	CcSEcCtD
Fentanyl—Nervousness—Epirubicin—uterine cancer	8.06e-05	0.000265	CcSEcCtD
Fentanyl—Back pain—Epirubicin—uterine cancer	8.03e-05	0.000264	CcSEcCtD
Fentanyl—Angiopathy—Doxorubicin—uterine cancer	8e-05	0.000263	CcSEcCtD
Fentanyl—Dizziness—Etoposide—uterine cancer	7.99e-05	0.000263	CcSEcCtD
Fentanyl—Muscle spasms—Epirubicin—uterine cancer	7.98e-05	0.000262	CcSEcCtD
Fentanyl—Immune system disorder—Doxorubicin—uterine cancer	7.97e-05	0.000262	CcSEcCtD
Fentanyl—Mediastinal disorder—Doxorubicin—uterine cancer	7.95e-05	0.000261	CcSEcCtD
Fentanyl—Chills—Doxorubicin—uterine cancer	7.92e-05	0.00026	CcSEcCtD
Fentanyl—Arrhythmia—Doxorubicin—uterine cancer	7.88e-05	0.000259	CcSEcCtD
Fentanyl—Vision blurred—Epirubicin—uterine cancer	7.82e-05	0.000257	CcSEcCtD
Fentanyl—Alopecia—Doxorubicin—uterine cancer	7.8e-05	0.000256	CcSEcCtD
Fentanyl—Mental disorder—Doxorubicin—uterine cancer	7.73e-05	0.000254	CcSEcCtD
Fentanyl—Ill-defined disorder—Epirubicin—uterine cancer	7.7e-05	0.000253	CcSEcCtD
Fentanyl—Vomiting—Etoposide—uterine cancer	7.68e-05	0.000252	CcSEcCtD
Fentanyl—Malnutrition—Doxorubicin—uterine cancer	7.68e-05	0.000252	CcSEcCtD
Fentanyl—Erythema—Doxorubicin—uterine cancer	7.68e-05	0.000252	CcSEcCtD
Fentanyl—Anaemia—Epirubicin—uterine cancer	7.67e-05	0.000252	CcSEcCtD
Fentanyl—Agitation—Epirubicin—uterine cancer	7.63e-05	0.000251	CcSEcCtD
Fentanyl—Rash—Etoposide—uterine cancer	7.62e-05	0.00025	CcSEcCtD
Fentanyl—Dermatitis—Etoposide—uterine cancer	7.61e-05	0.00025	CcSEcCtD
Fentanyl—Headache—Etoposide—uterine cancer	7.57e-05	0.000249	CcSEcCtD
Fentanyl—Flatulence—Doxorubicin—uterine cancer	7.57e-05	0.000249	CcSEcCtD
Fentanyl—Tension—Doxorubicin—uterine cancer	7.54e-05	0.000248	CcSEcCtD
Fentanyl—Dysgeusia—Doxorubicin—uterine cancer	7.52e-05	0.000247	CcSEcCtD
Fentanyl—Malaise—Epirubicin—uterine cancer	7.48e-05	0.000246	CcSEcCtD
Fentanyl—Nervousness—Doxorubicin—uterine cancer	7.46e-05	0.000245	CcSEcCtD
Fentanyl—Vertigo—Epirubicin—uterine cancer	7.46e-05	0.000245	CcSEcCtD
Fentanyl—Syncope—Epirubicin—uterine cancer	7.44e-05	0.000245	CcSEcCtD
Fentanyl—Leukopenia—Epirubicin—uterine cancer	7.43e-05	0.000244	CcSEcCtD
Fentanyl—Back pain—Doxorubicin—uterine cancer	7.43e-05	0.000244	CcSEcCtD
Fentanyl—Muscle spasms—Doxorubicin—uterine cancer	7.38e-05	0.000243	CcSEcCtD
Fentanyl—Palpitations—Epirubicin—uterine cancer	7.33e-05	0.000241	CcSEcCtD
Fentanyl—Loss of consciousness—Epirubicin—uterine cancer	7.29e-05	0.00024	CcSEcCtD
Fentanyl—Cough—Epirubicin—uterine cancer	7.24e-05	0.000238	CcSEcCtD
Fentanyl—Vision blurred—Doxorubicin—uterine cancer	7.24e-05	0.000238	CcSEcCtD
Fentanyl—Convulsion—Epirubicin—uterine cancer	7.19e-05	0.000236	CcSEcCtD
Fentanyl—Nausea—Etoposide—uterine cancer	7.18e-05	0.000236	CcSEcCtD
Fentanyl—Hypertension—Epirubicin—uterine cancer	7.17e-05	0.000235	CcSEcCtD
Fentanyl—Ill-defined disorder—Doxorubicin—uterine cancer	7.13e-05	0.000234	CcSEcCtD
Fentanyl—Anaemia—Doxorubicin—uterine cancer	7.1e-05	0.000233	CcSEcCtD
Fentanyl—Chest pain—Epirubicin—uterine cancer	7.07e-05	0.000232	CcSEcCtD
Fentanyl—Arthralgia—Epirubicin—uterine cancer	7.07e-05	0.000232	CcSEcCtD
Fentanyl—Myalgia—Epirubicin—uterine cancer	7.07e-05	0.000232	CcSEcCtD
Fentanyl—Agitation—Doxorubicin—uterine cancer	7.06e-05	0.000232	CcSEcCtD
Fentanyl—Anxiety—Epirubicin—uterine cancer	7.04e-05	0.000231	CcSEcCtD
Fentanyl—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	7.02e-05	0.000231	CcSEcCtD
Fentanyl—Discomfort—Epirubicin—uterine cancer	6.98e-05	0.000229	CcSEcCtD
Fentanyl—Malaise—Doxorubicin—uterine cancer	6.93e-05	0.000228	CcSEcCtD
Fentanyl—Dry mouth—Epirubicin—uterine cancer	6.91e-05	0.000227	CcSEcCtD
Fentanyl—Vertigo—Doxorubicin—uterine cancer	6.9e-05	0.000227	CcSEcCtD
Fentanyl—Syncope—Doxorubicin—uterine cancer	6.89e-05	0.000226	CcSEcCtD
Fentanyl—Leukopenia—Doxorubicin—uterine cancer	6.87e-05	0.000226	CcSEcCtD
Fentanyl—Confusional state—Epirubicin—uterine cancer	6.83e-05	0.000224	CcSEcCtD
Fentanyl—Palpitations—Doxorubicin—uterine cancer	6.79e-05	0.000223	CcSEcCtD
Fentanyl—Anaphylactic shock—Epirubicin—uterine cancer	6.77e-05	0.000223	CcSEcCtD
Fentanyl—Oedema—Epirubicin—uterine cancer	6.77e-05	0.000223	CcSEcCtD
Fentanyl—Loss of consciousness—Doxorubicin—uterine cancer	6.75e-05	0.000222	CcSEcCtD
Fentanyl—Infection—Epirubicin—uterine cancer	6.73e-05	0.000221	CcSEcCtD
Fentanyl—Cough—Doxorubicin—uterine cancer	6.7e-05	0.00022	CcSEcCtD
Fentanyl—Shock—Epirubicin—uterine cancer	6.66e-05	0.000219	CcSEcCtD
Fentanyl—Convulsion—Doxorubicin—uterine cancer	6.65e-05	0.000219	CcSEcCtD
Fentanyl—Nervous system disorder—Epirubicin—uterine cancer	6.64e-05	0.000218	CcSEcCtD
Fentanyl—Thrombocytopenia—Epirubicin—uterine cancer	6.63e-05	0.000218	CcSEcCtD
Fentanyl—Hypertension—Doxorubicin—uterine cancer	6.63e-05	0.000218	CcSEcCtD
Fentanyl—Tachycardia—Epirubicin—uterine cancer	6.61e-05	0.000217	CcSEcCtD
Fentanyl—Skin disorder—Epirubicin—uterine cancer	6.58e-05	0.000216	CcSEcCtD
Fentanyl—Hyperhidrosis—Epirubicin—uterine cancer	6.55e-05	0.000215	CcSEcCtD
Fentanyl—Myalgia—Doxorubicin—uterine cancer	6.54e-05	0.000215	CcSEcCtD
Fentanyl—Arthralgia—Doxorubicin—uterine cancer	6.54e-05	0.000215	CcSEcCtD
Fentanyl—Chest pain—Doxorubicin—uterine cancer	6.54e-05	0.000215	CcSEcCtD
Fentanyl—Anxiety—Doxorubicin—uterine cancer	6.52e-05	0.000214	CcSEcCtD
Fentanyl—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	6.49e-05	0.000213	CcSEcCtD
Fentanyl—Discomfort—Doxorubicin—uterine cancer	6.46e-05	0.000212	CcSEcCtD
Fentanyl—Anorexia—Epirubicin—uterine cancer	6.46e-05	0.000212	CcSEcCtD
Fentanyl—Dry mouth—Doxorubicin—uterine cancer	6.39e-05	0.00021	CcSEcCtD
Fentanyl—Hypotension—Epirubicin—uterine cancer	6.33e-05	0.000208	CcSEcCtD
Fentanyl—Confusional state—Doxorubicin—uterine cancer	6.32e-05	0.000208	CcSEcCtD
Fentanyl—Anaphylactic shock—Doxorubicin—uterine cancer	6.27e-05	0.000206	CcSEcCtD
Fentanyl—Oedema—Doxorubicin—uterine cancer	6.27e-05	0.000206	CcSEcCtD
Fentanyl—Infection—Doxorubicin—uterine cancer	6.23e-05	0.000205	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Epirubicin—uterine cancer	6.17e-05	0.000203	CcSEcCtD
Fentanyl—Shock—Doxorubicin—uterine cancer	6.17e-05	0.000203	CcSEcCtD
Fentanyl—Nervous system disorder—Doxorubicin—uterine cancer	6.15e-05	0.000202	CcSEcCtD
Fentanyl—Thrombocytopenia—Doxorubicin—uterine cancer	6.14e-05	0.000202	CcSEcCtD
Fentanyl—Insomnia—Epirubicin—uterine cancer	6.13e-05	0.000201	CcSEcCtD
Fentanyl—Tachycardia—Doxorubicin—uterine cancer	6.12e-05	0.000201	CcSEcCtD
Fentanyl—Skin disorder—Doxorubicin—uterine cancer	6.09e-05	0.0002	CcSEcCtD
Fentanyl—Paraesthesia—Epirubicin—uterine cancer	6.08e-05	0.0002	CcSEcCtD
Fentanyl—Hyperhidrosis—Doxorubicin—uterine cancer	6.06e-05	0.000199	CcSEcCtD
Fentanyl—Dyspnoea—Epirubicin—uterine cancer	6.04e-05	0.000198	CcSEcCtD
Fentanyl—Somnolence—Epirubicin—uterine cancer	6.02e-05	0.000198	CcSEcCtD
Fentanyl—Anorexia—Doxorubicin—uterine cancer	5.97e-05	0.000196	CcSEcCtD
Fentanyl—Dyspepsia—Epirubicin—uterine cancer	5.96e-05	0.000196	CcSEcCtD
Fentanyl—Decreased appetite—Epirubicin—uterine cancer	5.89e-05	0.000193	CcSEcCtD
Fentanyl—Hypotension—Doxorubicin—uterine cancer	5.86e-05	0.000192	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Epirubicin—uterine cancer	5.85e-05	0.000192	CcSEcCtD
Fentanyl—Fatigue—Epirubicin—uterine cancer	5.84e-05	0.000192	CcSEcCtD
Fentanyl—Pain—Epirubicin—uterine cancer	5.79e-05	0.00019	CcSEcCtD
Fentanyl—Constipation—Epirubicin—uterine cancer	5.79e-05	0.00019	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Doxorubicin—uterine cancer	5.71e-05	0.000188	CcSEcCtD
Fentanyl—Insomnia—Doxorubicin—uterine cancer	5.67e-05	0.000186	CcSEcCtD
Fentanyl—Paraesthesia—Doxorubicin—uterine cancer	5.63e-05	0.000185	CcSEcCtD
Fentanyl—Dyspnoea—Doxorubicin—uterine cancer	5.59e-05	0.000184	CcSEcCtD
Fentanyl—Feeling abnormal—Epirubicin—uterine cancer	5.58e-05	0.000183	CcSEcCtD
Fentanyl—Somnolence—Doxorubicin—uterine cancer	5.57e-05	0.000183	CcSEcCtD
Fentanyl—Gastrointestinal pain—Epirubicin—uterine cancer	5.54e-05	0.000182	CcSEcCtD
Fentanyl—Dyspepsia—Doxorubicin—uterine cancer	5.52e-05	0.000181	CcSEcCtD
Fentanyl—Decreased appetite—Doxorubicin—uterine cancer	5.45e-05	0.000179	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Doxorubicin—uterine cancer	5.41e-05	0.000178	CcSEcCtD
Fentanyl—Fatigue—Doxorubicin—uterine cancer	5.4e-05	0.000178	CcSEcCtD
Fentanyl—Urticaria—Epirubicin—uterine cancer	5.38e-05	0.000177	CcSEcCtD
Fentanyl—Pain—Doxorubicin—uterine cancer	5.36e-05	0.000176	CcSEcCtD
Fentanyl—Constipation—Doxorubicin—uterine cancer	5.36e-05	0.000176	CcSEcCtD
Fentanyl—Body temperature increased—Epirubicin—uterine cancer	5.35e-05	0.000176	CcSEcCtD
Fentanyl—Abdominal pain—Epirubicin—uterine cancer	5.35e-05	0.000176	CcSEcCtD
Fentanyl—Feeling abnormal—Doxorubicin—uterine cancer	5.16e-05	0.00017	CcSEcCtD
Fentanyl—Gastrointestinal pain—Doxorubicin—uterine cancer	5.13e-05	0.000168	CcSEcCtD
Fentanyl—Hypersensitivity—Epirubicin—uterine cancer	4.99e-05	0.000164	CcSEcCtD
Fentanyl—Urticaria—Doxorubicin—uterine cancer	4.98e-05	0.000164	CcSEcCtD
Fentanyl—Body temperature increased—Doxorubicin—uterine cancer	4.95e-05	0.000163	CcSEcCtD
Fentanyl—Abdominal pain—Doxorubicin—uterine cancer	4.95e-05	0.000163	CcSEcCtD
Fentanyl—Asthenia—Epirubicin—uterine cancer	4.86e-05	0.00016	CcSEcCtD
Fentanyl—Pruritus—Epirubicin—uterine cancer	4.79e-05	0.000157	CcSEcCtD
Fentanyl—Diarrhoea—Epirubicin—uterine cancer	4.63e-05	0.000152	CcSEcCtD
Fentanyl—Hypersensitivity—Doxorubicin—uterine cancer	4.62e-05	0.000152	CcSEcCtD
Fentanyl—Asthenia—Doxorubicin—uterine cancer	4.5e-05	0.000148	CcSEcCtD
Fentanyl—Dizziness—Epirubicin—uterine cancer	4.48e-05	0.000147	CcSEcCtD
Fentanyl—Pruritus—Doxorubicin—uterine cancer	4.43e-05	0.000146	CcSEcCtD
Fentanyl—Vomiting—Epirubicin—uterine cancer	4.31e-05	0.000141	CcSEcCtD
Fentanyl—Diarrhoea—Doxorubicin—uterine cancer	4.29e-05	0.000141	CcSEcCtD
Fentanyl—Rash—Epirubicin—uterine cancer	4.27e-05	0.00014	CcSEcCtD
Fentanyl—Dermatitis—Epirubicin—uterine cancer	4.27e-05	0.00014	CcSEcCtD
Fentanyl—Headache—Epirubicin—uterine cancer	4.24e-05	0.000139	CcSEcCtD
Fentanyl—Dizziness—Doxorubicin—uterine cancer	4.14e-05	0.000136	CcSEcCtD
Fentanyl—Nausea—Epirubicin—uterine cancer	4.02e-05	0.000132	CcSEcCtD
Fentanyl—Vomiting—Doxorubicin—uterine cancer	3.99e-05	0.000131	CcSEcCtD
Fentanyl—Rash—Doxorubicin—uterine cancer	3.95e-05	0.00013	CcSEcCtD
Fentanyl—Dermatitis—Doxorubicin—uterine cancer	3.95e-05	0.00013	CcSEcCtD
Fentanyl—Headache—Doxorubicin—uterine cancer	3.93e-05	0.000129	CcSEcCtD
Fentanyl—Nausea—Doxorubicin—uterine cancer	3.72e-05	0.000122	CcSEcCtD
